Trial intelligence / Profile preview

Sex Differences in THC-associated Reward in Cannabis Use Disorder

NCT07815691Phase 2Recruiting

Sponsor
Medical University of South Carolina
Start
Oct 2026
Primary completion
Jul 2031
Countries
1
01

Overview

A Phase 2 trial of dronabinol in cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Started Oct 2026; status: recruiting.

02

Drugs

dronabinol
03

Conditions

cannabis use disorder (CUD)

Beyond the preview

Go deeper on NCT07815691.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07815691.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call